<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Diderich, K.</title>
    <link>http://repub.eur.nl/res/aut/15768/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Phenotypic variability of atypical 22q11.2 deletions not including TBX1 (Article)</title>
      <link>http://repub.eur.nl/res/pub/37406/</link>
      <pubDate>2012-10-01T00:00:00Z</pubDate>
      <description>Interstitial deletions of the chromosome 22q11.2 region are the most common microdeletions in humans. The TBX1 gene is considered to be the major candidate gene for the main features in 22q11.2 deletion syndrome, including congenital heart malformations, (para)thyroid hypoplasia, and craniofacial abnormalities. We report on eight patients with atypical deletions of chromosome 22q11.2. These deletions comprise the distal part of the common 22q11.2 deleted region but do not encompass the TBX1 gene. Ten similar patients with overlapping distal 22q11.2 deletions have been reported previously. The clinical features of these patients are described and compared to those found in the classic 22q11.2 deletion syndrome. We discuss the possible roles of a position effect or haploinsufficiency of distally located genes (e.g., CRKL) in the molecular pathogenesis of the 22q11.2 deletion syndrome. </description>
    </item> <item>
      <title>Bone fragility and decline in stem cells in prematurely aging DNA repair deficient trichothiodystrophy mice (Article)</title>
      <link>http://repub.eur.nl/res/pub/33640/</link>
      <pubDate>2012-08-01T00:00:00Z</pubDate>
      <description>Trichothiodystrophy (TTD) is a rare, autosomal recessive nucleotide excision repair (NER) disorder caused by mutations in components of the dual functional NER/basal transcription factor TFIIH. TTD mice, carrying a patient-based point mutation in the Xpd gene, strikingly resemble many features of the human syndrome and exhibit signs of premature aging. To examine to which extent TTD mice resemble the normal process of aging, we thoroughly investigated the bone phenotype. Here, we show that female TTD mice exhibit accelerated bone aging from 39 weeks onwards as well as lack of periosteal apposition leading to reduced bone strength. Before 39 weeks have passed, bones of wild-type and TTD mice are identical excluding a developmental defect. Albeit that bone formation is decreased, osteoblasts in TTD mice retain bone-forming capacity as in vivo PTH treatment leads to increased cortical thickness. In vitro bone marrow cell cultures showed that TTD osteoprogenitors retain the capacity to differentiate into osteoblasts. However, after 13 weeks of age TTD females show decreased bone nodule formation. No increase in bone resorption or the number of osteoclasts was detected. In conclusion, TTD mice show premature bone aging, which is preceded by a decrease in mesenchymal stem cells/osteoprogenitors and a change in systemic factors, identifying DNA damage and repair as key determinants for bone fragility by influencing osteogenesis and bone metabolism. </description>
    </item> <item>
      <title>Age-related skeletal dynamics and decrease in bone strength in DNA repair deficient male trichothiodystrophy mice (Article)</title>
      <link>http://repub.eur.nl/res/pub/39306/</link>
      <pubDate>2012-04-10T00:00:00Z</pubDate>
      <description>Accumulation of DNA damage caused by oxidative stress is thought to be one of the main contributors of human tissue aging. Trichothiodystrophy (TTD) mice have a mutation in the Ercc2 DNA repair gene, resulting in accumulation of DNA damage and several features of segmental accelerated aging. We used male TTD mice to study the impact of DNA repair on bone metabolism with age. Analysis of bone parameters, measured by micro-computed tomography, displayed an earlier decrease in trabecular and cortical bone as well as a loss of periosteal apposition and a reduction in bone strength in TTD mice with age compared to wild type mice. Ex vivo analysis of bone marrow differentiation potential showed an accelerated reduction in the number of osteogenic and osteoprogenitor cells with unaltered differentiation capacity. Adipocyte differentiation was normal. Early in life, osteoclast number tended to be increased while at 78 weeks it was significantly lower in TTD mice. Our findings reveal the importance of genome stability and proper DNA repair for skeletal homeostasis with age and support the idea that accumulation of damage interferes with normal skeletal maintenance, causing reduction in the number of osteoblast precursors that are required for normal bone remodeling leading to a loss of bone structure and strength. </description>
    </item> <item>
      <title>Premature aging and cancer in nucleotide excision repair-disorders (Article)</title>
      <link>http://repub.eur.nl/res/pub/34475/</link>
      <pubDate>2011-07-15T00:00:00Z</pubDate>
      <description>During the past decades, the major impact of DNA damage on cancer as 'disease of the genes' has become abundantly apparent. In addition to cancer, recent years have also uncovered a very strong association of DNA damage with many features of (premature) aging. The notion that DNA repair systems protect not only against cancer but also equally against to fast aging has become evident from a systematic, integral analysis of a variety of mouse mutants carrying defects in e.g. transcription-coupled repair with or without an additional impairment of global genome nucleotide excision repair and the corresponding segmental premature aging syndromes in human. A striking correlation between the degree of the DNA repair deficiency and the acceleration of specific progeroid symptoms has been discovered for those repair systems that primarily protect from the cytotoxic and cytostatic effects of DNA damage. These observations are explained from the perspective of nucleotide excision repair mouse mutant and human syndromes. However, similar principles likely apply to other DNA repair pathways including interstrand crosslink repair and double strand break repair and genome maintenance systems in general, supporting the notion that DNA damage constitutes an important intermediate in the process of aging. </description>
    </item> <item>
      <title>Bone Aging in DNA Repair Deficient Trichothiodystrophy Mice (Doctoral Thesis)</title>
      <link>http://repub.eur.nl/res/pub/17723/</link>
      <pubDate>2010-01-06T00:00:00Z</pubDate>
      <description>Our genome is continuously damaged by environmental, endogenous agents as well as by
the instrinsic instability of DNA. For example, UV light gives rise to helix-distorting cyclobutane
pyrimidine dimers (CPDs) and pyrimidine-(6,4)-pyrimidone adducts (6-4PPs). Ionizing
radiation can cause both single and double strand breaks in DNA and numerous types of oxidative
lesions. Chemotherapeutics, that are used in cancer therapy, and other environmental
chemical agents, which are present in e.g. polluted air and tobacco smoke, induce a plethora
of DNA lesions, including intra- and inter-strand cross-links and mono-adducts. In addition,
endogenous agents cause a wide variety of DNA lesions. Metabolic processes within our cells
lead to reactive oxygen species (ROS), which react with proteins, lipids and DNA. Although
ROS participate in beneficial physiological processes as growth factor signal transduction,
these by-products of metabolism also underlie a broad spectrum of oxidative DNA lesions,
including 8-oxo-2’-deoxyguanosine (8-oxodG), thymine glycols, cylcopurines, as well as
single and double strand breaks. Finally, lesions in the DNA can also form without a direct
damaging agent. E.g. spontaneous hydrolysis or modifications of nucleotides occurs in cells,
which leaves non-informative a-basic sites or altered, miscoding nucleotides.</description>
    </item> <item>
      <title>Symptomatic hypoparathyroidism based on a 22qII deletion first diagnosed in a 43-year-old woman (Article)</title>
      <link>http://repub.eur.nl/res/pub/16602/</link>
      <pubDate>2009-01-01T00:00:00Z</pubDate>
      <description>Congenital hypoparathyroidism usually manifests in early childhood with hypocalcaemia with or without clinical characteristics. This report describes a Caucasian woman who, at the age of 43 years, was diagnosed with dysgenesis of the parathyroid glands due to a de novo microdeletion in chromosome 22q11 or DiGeorge syndrome. This syndrome is characterised by a considerable variability in clinical symptoms, including heart defects, thymic hypoplasia and mental retardation. Our patient presented with generalised convulsions due to extreme, symptomatic hypocalcaemia. The convulsions had been apparent for 18 months at the time of the diagnosis. Remarkably, whereas parathyroid hormone levels were undetectable, the 1,25-dihydroxy vitamin D level was normal. Chromosome 22q11 deletion was confirmed by fluorescence in situ hybridisation analysis.</description>
    </item> <item>
      <title>Impaired genome maintenance suppresses the growth hormone--insulin-like growth factor 1 axis in mice with Cockayne syndrome. (Article)</title>
      <link>http://repub.eur.nl/res/pub/37065/</link>
      <pubDate>2006-12-12T00:00:00Z</pubDate>
      <description>Cockayne syndrome (CS) is a photosensitive, DNA repair disorder associated with progeria that is caused by a defect in the transcription-coupled repair subpathway of nucleotide excision repair (NER). Here, complete inactivation of NER in Csb(m/m)/Xpa(-/-) mutants causes a phenotype that reliably mimics the human progeroid CS syndrome. Newborn Csb(m/m)/Xpa(-/-) mice display attenuated growth, progressive neurological dysfunction, retinal degeneration, cachexia, kyphosis, and die before weaning. Mouse liver transcriptome analysis and several physiological endpoints revealed systemic suppression of the growth hormone/insulin-like growth factor 1 (GH/IGF1) somatotroph axis and oxidative metabolism, increased antioxidant responses, and hypoglycemia together with hepatic glycogen and fat accumulation. Broad genome-wide parallels between Csb(m/m)/Xpa(-/-) and naturally aged mouse liver transcriptomes suggested that these changes are intrinsic to natural ageing and the DNA repair-deficient mice. Importantly, wild-type mice exposed to a low dose of chronic genotoxic stress recapitulated this response, thereby pointing to a novel link between genome instability and the age-related decline of the somatotroph axis.</description>
    </item> <item>
      <title>Dysregulation of the peroxisome proliferator-activated receptor target genes by XPD mutations. (Article)</title>
      <link>http://repub.eur.nl/res/pub/13845/</link>
      <pubDate>2005-07-01T00:00:00Z</pubDate>
      <description>Mutations in the XPD subunit of TFIIH give rise to human genetic disorders initially defined as DNA repair syndromes. Nevertheless, xeroderma pigmentosum (XP) group D (XP-D) patients develop clinical features such as hypoplasia of the adipose tissue, implying a putative transcriptional defect. Knowing that peroxisome proliferator-activated receptors (PPARs) are implicated in lipid metabolism, we investigated the expression of PPAR target genes in the adipose tissues and the livers of XPD-deficient mice and found that (i) some genes are abnormally overexpressed in a ligand-independent manner which parallels an increase in the recruitment of RNA polymerase (pol) II but not PPARs on their promoter and (ii) upon treatment with PPAR ligands, other genes are much less induced compared to the wild type, which is due to a lower recruitment of both PPARs and RNA pol II. The defect in transactivation by PPARs is likely attributable to their weaker phosphorylation by the cdk7 kinase of TFIIH. Having identified the phosphorylated residues in PPAR isotypes, we demonstrate how their transactivation defect in XPD-deficient cells can be circumvented by overexpression of either a wild-type XPD or a constitutively phosphorylated PPAR S/E. This work emphasizes that underphosphorylation of PPARs affects their transactivation and consequently the expression of PPAR target genes, thus contributing in part to the XP-D phenotype.</description>
    </item>
  </channel>
</rss>